StockData
Rockwell Medical, Inc. logo

Rockwell Medical, Inc. (RMTI) stock

RMTINasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 11/3080% below fair value
$6.61−0.15 (-2.22%)

Close on Nov 17, 2026Market cap $26.64MP/E –Yield –

Rockwell Medical ebitda

EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.

Rockwell Medical's ebitda for the twelve months ending Jun 30, 2026 was -$2.43M, down 371.2% year over year. For fiscal 2025 it was -$2.50M, down 189.6% from the year before. The highest annual figure on record is $2.79M in fiscal 2024.

Annual ebitda

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$2.50M-189.6%
FY2024Dec 31, 2024$2.79M–
FY2023Dec 31, 2023-$5.23M–
FY2022Dec 31, 2022-$16.20M–
FY2021Dec 31, 2021-$29.67M–
FY2020Dec 31, 2020-$27.59M–
FY2019Dec 31, 2019-$33.74M–
FY2018Dec 31, 2018-$31.79M–
FY2017Dec 31, 2017-$25.41M–
FY2016Dec 31, 2016-$19.45M–
FY2015Dec 31, 2015-$14.28M–
FY2014Dec 31, 2014-$16.56M–
FY2013Dec 31, 2013-$46.05M–
FY2012Dec 31, 2012-$53.17M–
FY2011Dec 31, 2011-$20.51M–
FY2010Dec 31, 2010-$1.48M–
FY2009Dec 31, 2009-$4.25M–

Quarterly ebitda

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026-$569.00K–
Q1 FY2026Mar 31, 2026-$969.00K–
Q4 FY2025Dec 31, 2025$148.00K+516.7%
Q3 FY2025Sep 30, 2025-$1.04M-142.0%
Q2 FY2025Jun 30, 2025-$786.00K-173.9%
Q1 FY2025Mar 31, 2025-$821.00K–
Q4 FY2024Dec 31, 2024$24.00K+700.0%
Q3 FY2024Sep 30, 2024$2.48M–
Q2 FY2024Jun 30, 2024$1.06M–
Q1 FY2024Mar 31, 2024-$779.00K–
Q4 FY2023Dec 31, 2023$3.00K–
Q3 FY2023Sep 30, 2023-$1.17M–
Q2 FY2023Jun 30, 2023-$2.79M–
Q1 FY2023Mar 31, 2023-$1.27M–
Q4 FY2022Dec 31, 2022-$1.81M–
Q3 FY2022Sep 30, 2022-$3.57M–
Q2 FY2022Jun 30, 2022-$4.34M–
Q1 FY2022Mar 31, 2022-$6.49M–
Q4 FY2021Dec 31, 2021-$8.23M–
Q3 FY2021Sep 30, 2021-$6.82M–
Q2 FY2021Jun 30, 2021-$7.64M–
Q1 FY2021Mar 31, 2021-$6.98M–
Q4 FY2020Dec 31, 2020-$7.85M–
Q3 FY2020Sep 30, 2020-$6.48M–
Q2 FY2020Jun 30, 2020-$5.40M–
Q1 FY2020Mar 31, 2020-$7.85M–
Q4 FY2019Dec 31, 2019-$7.20M–
Q3 FY2019Sep 30, 2019-$7.74M–
Q2 FY2019Jun 30, 2019-$10.18M–
Q1 FY2019Mar 31, 2019-$8.62M–
Q4 FY2018Dec 31, 2018-$9.24M–
Q3 FY2018Sep 30, 2018-$4.81M–
Q2 FY2018Jun 30, 2018-$12.14M–
Q1 FY2018Mar 31, 2018-$5.59M–
Q4 FY2017Dec 31, 2017-$9.09M–
Q3 FY2017Sep 30, 2017-$4.90M–
Q2 FY2017Jun 30, 2017-$6.59M–
Q1 FY2017Mar 31, 2017-$4.83M–
Q4 FY2016Dec 31, 2016-$5.08M–
Q3 FY2016Sep 30, 2016-$4.56M–

More Rockwell Medical figures

See a number that looks wrong?